Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA Cancer J Clin (2015) 0.93

The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention. Transl Lung Cancer Res (2015) 0.91

ALK-rearrangements and testing methods in non-small cell lung cancer: a review. Genes Cancer (2014) 0.90

Lung cancer screening with low-dose computed tomography for primary care providers. Prim Care (2014) 0.90

Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention. Genome Med (2014) 0.89

Epidemiology of Lung Cancer in Korea: Recent Trends. Tuberc Respir Dis (Seoul) (2016) 0.88

Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 0.88

Mechanisms of immune response regulation in lung cancer. Transl Lung Cancer Res (2014) 0.86

Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer. Int J Clin Exp Med (2015) 0.86

Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics. ScientificWorldJournal (2014) 0.85

Interactions between paraoxonase 1 genetic polymorphisms and smoking and their effects on oxidative stress and lung cancer risk in a Korean population. PLoS One (2015) 0.84

Time trends in municipal distribution patterns of cancer mortality in Spain. BMC Cancer (2014) 0.84

The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer. J Epidemiol (2014) 0.84

Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer. Cancer Control (2016) 0.82

Increased methylation of lung cancer-associated genes in sputum DNA of former smokers with chronic mucous hypersecretion. Respir Res (2014) 0.82

The Treg/Th17 paradigm in lung cancer. J Immunol Res (2014) 0.82

Hidden treasures in "ancient" microarrays: gene-expression portrays biology and potential resistance pathways of major lung cancer subtypes and normal tissue. Front Oncol (2014) 0.81

Curcumin increases exosomal TCF21 thus suppressing exosome-induced lung cancer. Oncotarget (2016) 0.80

Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients. World J Surg Oncol (2014) 0.79

Medicinal Plants and Other Living Organisms with Antitumor Potential against Lung Cancer. Evid Based Complement Alternat Med (2014) 0.78

Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. Mol Med Rep (2015) 0.78

Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions. J Thorac Oncol (2015) 0.78

Clinicopathological and prognostic significance of heat shock protein 27 (HSP27) expression in non-small cell lung cancer: a systematic review and meta-analysis. Springerplus (2016) 0.77

Decreased IL-27 Negatively Correlated with Th17 Cells in Non-Small-Cell Lung Cancer Patients. Mediators Inflamm (2015) 0.77

Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study. PLoS One (2017) 0.77

Prognostic significance of osteopontin in patients with non-small cell lung cancer: results from a meta-analysis. Int J Clin Exp Med (2015) 0.77

Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer. PLoS One (2015) 0.77

Retrospective Study to Determine Diagnostic Utility of 6 Commonly Used Lung Cancer Biomarkers Among Han and Uygur Population in Xinjiang Uygur Autonomous Region of People's Republic of China. Medicine (Baltimore) (2016) 0.77

A Healthy Dietary Pattern Reduces Lung Cancer Risk: A Systematic Review and Meta-Analysis. Nutrients (2016) 0.77

Sleep duration and risk of lung cancer in the physicians' health study. Zhongguo Fei Ai Za Zhi (2014) 0.77

AZD0530 sensitizes drug-resistant ALK-positive lung cancer cells by inhibiting SRC signaling. FEBS Open Bio (2017) 0.75

Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies. Microarrays (Basel) (2015) 0.75

Aspirin use and lung cancer risk: a possible relationship? Evidence from an updated meta-analysis. PLoS One (2015) 0.75

Tankyrase 1 polymorphism associated with an increased risk in developing non-small cell lung cancer in a Chinese population: a proof-of-principle study. Int J Clin Exp Pathol (2015) 0.75

Risk factors assessment and risk prediction models in lung cancer screening candidates. Ann Transl Med (2016) 0.75

Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung. Int J Clin Exp Pathol (2015) 0.75

Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer. Cancer Med (2016) 0.75

Weaknesses and Pitfalls of Using Mice and Rats in Cancer Chemoprevention Studies. J Cancer (2015) 0.75

Comments on characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis. J Thorac Dis (2015) 0.75

Clinical and prognostic significance of Merkel cell polyomavirus in nonsmall cell lung cancer. Medicine (Baltimore) (2017) 0.75

Identification of FGF19 as a prognostic marker and potential driver gene of lung squamous cell carcinomas in Chinese smoking patients. Oncotarget (2016) 0.75

Gene-expression profiles in lung adenocarcinomas related to chronic wood smoke or tobacco exposure. Respir Res (2016) 0.75

Design and implementation of a mobile system for lung cancer patient follow-up in China and initial report of the ongoing patient registry. Oncotarget (2016) 0.75

Effects of CYP3A5 genetic polymorphism and smoking on the prognosis of non-small-cell lung cancer. Onco Targets Ther (2016) 0.75

Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep (2017) 0.75

Minimally Invasive Methods for Staging in Lung Cancer: Systematic Review and Meta-Analysis. Pulm Med (2016) 0.75

Association between the COMT 158 G/A polymorphism and lung cancer risk: a meta-analysis. Int J Clin Exp Med (2015) 0.75

Genome Wide Methylome Alterations in Lung Cancer. PLoS One (2015) 0.75

Biomimetic Cross-Reactive Sensor Arrays: Prospects in Biodiagnostics. RSC Adv (2016) 0.75

Lung Cancer Gene Signatures and Clinical Perspectives. Microarrays (Basel) (2013) 0.75

Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis. Oncotarget (2017) 0.75

Reduced RKIP expression levels are associated with frequent non-small cell lung cancer metastasis and STAT3 phosphorylation and activation. Oncol Lett (2017) 0.75

Using Clinical Risk Models for Lung Nodule Classification. Semin Thorac Cardiovasc Surg (2015) 0.75

Historical Perspectives of the Causation of Lung Cancer: Nursing as a Bystander. Glob Qual Nurs Res (2015) 0.75

Prognostic impact of M descriptors of the 8th edition of TNM classification of lung cancer. J Thorac Dis (2017) 0.75

Cardiac glycosides use and the risk of lung cancer: a nested case-control study. BMC Cancer (2014) 0.75

Germline mutations in DNA repair genes in lung adenocarcinoma. J Thorac Oncol (2017) 0.75

HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer. J Cancer (2017) 0.75

Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer. Biosci Rep (2017) 0.75

Does lung cancer surgery cause circulating tumor cells?-A multicenter, prospective study. J Thorac Dis (2017) 0.75

Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients. Oncotarget (2017) 0.75

Undertreatment trend in elderly lung cancer patients in Brazil. J Cancer Res Clin Oncol (2017) 0.75

Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection. BMC Infect Dis (2017) 0.75

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22

An association between air pollution and mortality in six U.S. cities. N Engl J Med (1993) 38.84

Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med (2011) 38.61

Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA (2002) 28.72

The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 25.60

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med (2002) 24.87

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst (1989) 19.87

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature (2008) 18.21

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol (2008) 17.30

Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48

Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet (2008) 16.17

A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature (2008) 16.10

Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum (2004) 14.27

Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med (2009) 11.51

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06

Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med (2009) 10.31

Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med (2009) 10.27

Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet (2011) 9.37

The role of DNA methylation in mammalian epigenetics. Science (2001) 9.26

Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst (1999) 8.59

Perceptions of epigenetics. Nature (2007) 8.43

Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36

Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med (2006) 7.82

Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health (1978) 7.80

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71

Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A (2003) 7.44

Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (2006) 7.08

Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 6.69

Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ (2004) 6.48

Tobacco use among U.S. racial/ethnic minority groups--African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, Hispanics. A Report of the Surgeon General. Executive summary. MMWR Recomm Rep (1998) 6.48

Lung cancer in never smokers--a different disease. Nat Rev Cancer (2007) 6.41

Mortality from lung cancer in asbestos workers. Br J Ind Med (1955) 5.77

Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09

Variations in lung cancer risk among smokers. J Natl Cancer Inst (2003) 5.00

Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst (1996) 4.91

Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci U S A (2004) 4.89

Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med (1998) 4.72

Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med (2007) 4.63

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol (2009) 4.38

Lung cancer and indoor air pollution in Xuan Wei, China. Science (1987) 4.36

Exposure to diesel motor exhaust and lung cancer risk in a pooled analysis from case-control studies in Europe and Canada. Am J Respir Crit Care Med (2010) 4.35

Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.29

Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA (2006) 4.27

A risk model for prediction of lung cancer. J Natl Cancer Inst (2007) 4.25

Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol (2003) 4.22

Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86). Radiat Res (1990) 4.18

Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol (2003) 4.15

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A (2011) 4.11

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Silica, Some Silicates, Coal Dust and Para-Aramid Fibrils. Lyon, 15-22 October 1996. IARC Monogr Eval Carcinog Risks Hum (1997) 3.85

A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76

Long-term effects of traffic-related air pollution on mortality in a Dutch cohort (NLCS-AIR study). Environ Health Perspect (2008) 3.70

Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet (1999) 3.70

Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer (1987) 3.69

The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol (2001) 3.59

HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis (2007) 3.56

A review of human carcinogens--Part C: metals, arsenic, dusts, and fibres. Lancet Oncol (2009) 3.47

Household stove improvement and risk of lung cancer in Xuanwei, China. J Natl Cancer Inst (2002) 3.45

Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr (2008) 3.44

Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst (2004) 3.43

MORTALITY OF GASWORKERS WITH SPECIAL REFERENCE TO CANCERS OF THE LUNG AND BLADDER, CHRONIC BRONCHITIS, AND PNEUMOCONIOSIS. Br J Ind Med (1965) 3.41

Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev (2005) 3.40

Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med (2000) 3.36

Epidemiology of lung cancer. Chest (2003) 3.35

Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol (1993) 3.33

Lung cancer incidence in never smokers. J Clin Oncol (2007) 3.20

Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol (2009) 3.16

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res (1999) 3.15

The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer (2007) 3.15

Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer (2004) 3.10

Long-term mortality study of steelworkers. V. Respiratory cancer in coke plant workers. J Occup Med (1971) 3.09

Detection of lung cancer with volatile markers in the breath. Chest (2003) 3.09

Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res (2006) 3.05

A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05

Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA (2010) 2.99

Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med (2005) 2.94

Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med (2008) 2.90

Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes Control (2003) 2.88

Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res (2009) 2.77

Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol (2006) 2.66

Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers. Am J Respir Crit Care Med (2011) 2.64

Occupational exposure to crystalline silica and risk of lung cancer: a multicenter case-control study in Europe. Epidemiology (2007) 2.60

Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology (2005) 2.56

Socioeconomic and racial differences in lung cancer incidence. Am J Epidemiol (1983) 2.54

Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol (2006) 2.46

Patterns of mortality in asbestos factory workers in London. Ann N Y Acad Sci (1979) 2.40

Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis (1991) 2.34

An association between long-term exposure to ambient air pollution and mortality from lung cancer and respiratory diseases in Japan. J Epidemiol (2011) 2.33

Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J Natl Cancer Inst (1995) 2.30

Effects of cigarette smoke on the human oral mucosal transcriptome. Cancer Prev Res (Phila) (2010) 2.30

R.J. Reynolds' targeting of African Americans: 1988-2000. Am J Public Health (2003) 2.29

Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med (2003) 2.28

Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet (2008) 2.27

A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control (2003) 2.24

Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer (2001) 2.23

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer (2010) 2.20

Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them. BMJ (2009) 2.20

Updated analyses of combined mortality data for workers at the Hanford Site, Oak Ridge National Laboratory, and Rocky Flats Weapons Plant. Radiat Res (1993) 2.19

A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med (2006) 2.16

Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA (2006) 13.43

Temperature and mortality in 11 cities of the eastern United States. Am J Epidemiol (2002) 9.88

Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med (2005) 7.61

Ozone and short-term mortality in 95 US urban communities, 1987-2000. JAMA (2004) 7.52

Body-mass index and mortality in Korean men and women. N Engl J Med (2006) 7.50

Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A (2003) 7.44

Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med (2009) 7.06

Fasting serum glucose level and cancer risk in Korean men and women. JAMA (2005) 6.69

Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet (2012) 6.49

Relation between elevated ambient temperature and mortality: a review of the epidemiologic evidence. Epidemiol Rev (2002) 6.46

Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med (2002) 5.98

Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med (2006) 5.80

On the use of generalized additive models in time-series studies of air pollution and health. Am J Epidemiol (2002) 5.05

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet (2004) 5.01

Mortality attributable to smoking in China. N Engl J Med (2009) 4.75

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet (2012) 4.70

Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res (2007) 4.65

Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov (2011) 4.60

A meta-analysis of time-series studies of ozone and mortality with comparison to the national morbidity, mortality, and air pollution study. Epidemiology (2005) 4.60

Spatial and temporal variation in PM(2.5) chemical composition in the United States for health effects studies. Environ Health Perspect (2007) 4.39

Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.29

Seasonal analyses of air pollution and mortality in 100 US cities. Am J Epidemiol (2005) 3.94

Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell (2012) 3.82

PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. Mol Cancer Res (2006) 3.72

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68

Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol (2002) 3.66

The global burden of disease due to outdoor air pollution. J Toxicol Environ Health A (2005) 3.43

Emergency admissions for cardiovascular and respiratory diseases and the chemical composition of fine particle air pollution. Environ Health Perspect (2009) 3.41

Hospital admissions and chemical composition of fine particle air pollution. Am J Respir Crit Care Med (2009) 3.38

Epidemiology of lung cancer. Chest (2003) 3.35

Coarse particulate matter air pollution and hospital admissions for cardiovascular and respiratory diseases among Medicare patients. JAMA (2008) 3.04

Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med (2007) 2.81

Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med (2004) 2.62

Hospital admissions for heart disease: the effects of temperature and humidity. Epidemiology (2004) 2.49

Smoking and cancer risk in Korean men and women. Cancer Causes Control (2004) 2.46

Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol (2006) 2.46

Validity of messenger RNA expression analyses of human saliva. Clin Cancer Res (2006) 2.46

Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med (2003) 2.39

Secondhand smoke exposure among women and children: evidence from 31 countries. Am J Public Health (2008) 2.37

Air pollution and health: a European and North American approach (APHENA). Res Rep Health Eff Inst (2009) 2.33

Epidemiology of lung cancer: looking to the future. J Clin Oncol (2005) 2.33

Fast and accurate inference of local ancestry in Latino populations. Bioinformatics (2012) 2.30

Particulate air pollution and mortality in the United States: did the risks change from 1987 to 2000? Am J Epidemiol (2007) 2.29

Fine particulate matter and mortality: a comparison of the six cities and American Cancer Society cohorts with a medicare cohort. Epidemiology (2008) 2.25

Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med (2002) 2.24

Time-series studies of particulate matter. Annu Rev Public Health (2004) 2.23

Revised analyses of the National Morbidity, Mortality, and Air Pollution Study: mortality among residents of 90 cities. J Toxicol Environ Health A (2005) 2.21

Outdoor particulate matter exposure and lung cancer: a systematic review and meta-analysis. Environ Health Perspect (2014) 2.20

Seasonal and regional short-term effects of fine particles on hospital admissions in 202 US counties, 1999-2005. Am J Epidemiol (2008) 2.20

Airborne particulate matter and mortality: timescale effects in four US cities. Am J Epidemiol (2003) 2.13

Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clin Cancer Res (2004) 1.93

Building capacity for international tobacco control research: the global tobacco research network. Am J Public Health (2005) 1.91

Body mass index and cancer risk in Korean men and women. Int J Cancer (2008) 1.89

Mortality in the Medicare population and chronic exposure to fine particulate air pollution in urban centers (2000-2005). Environ Health Perspect (2008) 1.89

National maps of the effects of particulate matter on mortality: exploring geographical variation. Environ Health Perspect (2003) 1.86

Smoking among adolescents in China: 1998 survey findings. Int J Epidemiol (2004) 1.81

Variation in symptoms of sleep-disordered breathing with race and ethnicity: the Sleep Heart Health Study. Sleep (2003) 1.81

Defining a gene promoter methylation signature in sputum for lung cancer risk assessment. Clin Cancer Res (2012) 1.80

Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol (2009) 1.78

State-of-the-science workshop report: issues and approaches in low-dose-response extrapolation for environmental health risk assessment. Environ Health Perspect (2008) 1.77

Development of a panel of genome-wide ancestry informative markers to study admixture throughout the Americas. PLoS Genet (2012) 1.74

Does the effect of PM10 on mortality depend on PM nickel and vanadium content? A reanalysis of the NMMAPS data. Environ Health Perspect (2007) 1.73

Temperature and mortality among the elderly in the United States: a comparison of epidemiologic methods. Epidemiology (2005) 1.70

Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging. Ann Thorac Surg (2012) 1.69

Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials. Clin Trials (2006) 1.68

Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer (2007) 1.67

Emergency hospital admissions for cardiovascular diseases and ambient levels of carbon monoxide: results for 126 United States urban counties, 1999-2005. Circulation (2009) 1.65

Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol (2011) 1.59

The effect of volume on esophageal cancer resections: what constitutes acceptable resection volumes for centers of excellence? J Thorac Cardiovasc Surg (2009) 1.55

Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res (2009) 1.55

Time for oncologists to opt in for routine opt-out HIV testing? JAMA (2010) 1.53

Moving beyond global tobacco control to global disease control. Tob Control (2011) 1.50

The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. J Oncol Pract (2013) 1.48

Reducing disparities in asthma care: priorities for research--National Heart, Lung, and Blood Institute workshop report. J Allergy Clin Immunol (2002) 1.48

ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am J Respir Crit Care Med (2003) 1.47

Applying justice in clinical trials for diverse populations. Clin Trials (2007) 1.46

Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study. J Thorac Cardiovasc Surg (2002) 1.46

Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res (2004) 1.45

Potential mRNA degradation targets of hsa-miR-200c, identified using informatics and qRT-PCR. Cell Cycle (2006) 1.45

Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst (2004) 1.44

Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin Cancer Res (2009) 1.44

Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine. Oncotarget (2013) 1.44

Assessing secondhand smoke using biological markers. Tob Control (2012) 1.44

Is there evidence for synergy among air pollutants in causing health effects? Environ Health Perspect (2008) 1.42

The use of "overall accuracy" to evaluate the validity of screening or diagnostic tests. J Gen Intern Med (2004) 1.41

Environmental monitoring of secondhand smoke exposure. Tob Control (2012) 1.39

Causal inference in public health. Annu Rev Public Health (2013) 1.38

An exposure assessment study of ambient heat exposure in an elderly population in Baltimore, Maryland. Environ Health Perspect (2002) 1.35

Smoking and risk for diabetes incidence and mortality in Korean men and women. Diabetes Care (2010) 1.34

CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma. Am J Respir Crit Care Med (2005) 1.34

Commentary: Does air pollution confound studies of temperature? Epidemiology (2014) 1.29

Second-hand smoke's worldwide disease toll. Lancet (2010) 1.29

Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. Am J Kidney Dis (2008) 1.28

Outdoor air pollution and acute respiratory infections among children in developing countries. J Occup Environ Med (2002) 1.28

Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response? J Thorac Cardiovasc Surg (2009) 1.27

Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Clin Cancer Res (2006) 1.26

Is the air pollution health research community prepared to support a multipollutant air quality management framework? Inhal Toxicol (2010) 1.24

Associations of weight, weight change, and body mass with breast cancer risk in Hispanic and non-Hispanic white women. Ann Epidemiol (2002) 1.23